Barr, E. K., Naranjo, A., Twist, C. J., Tenney, S. C., Schmidt, M. L., London, W. B., . . . Cohn, S. L. (2024). Long‐term follow‐up of patients with intermediate‐risk neuroblastoma treated with response‐ and biology‐based therapy: A report from the Children's Oncology Group study ANBL0531. Pediatric Blood & Cancer, 71(8), 1-11. https://doi.org/10.1002/pbc.31089

Barr, Erin K., et al. "Long‐term Follow‐up of Patients with Intermediate‐risk Neuroblastoma Treated with Response‐ and Biology‐based Therapy: A Report from the Children's Oncology Group Study ANBL0531." Pediatric Blood & Cancer 71, no. 8 (2024): 1-11. https://doi.org/10.1002/pbc.31089.

Barr, Erin K., et al. "Long‐term Follow‐up of Patients with Intermediate‐risk Neuroblastoma Treated with Response‐ and Biology‐based Therapy: A Report from the Children's Oncology Group Study ANBL0531." Pediatric Blood & Cancer, vol. 71, no. 8, 2024, pp. 1-11, https://doi.org/10.1002/pbc.31089.